Research progress on speciation analysis of arsenic in traditional Chinese medicine

Author:

Peng Congnan1,Zhou Juntong1,Li Chi2,Chen Yuxin1,Huo Qing1,Xie Fei1

Affiliation:

1. Department of Biomedicine, Biochemical Engineering College of Beijing Union University , 100023 Beijing , China

2. Department of Chinese Medicine, Beijing City University , 100083 Beijing , China

Abstract

Abstract Traditional Chinese medicine contains arsenic (As), which in the natural environment accumulates in plants during the growth of Chinese medicinal materials; there are mineral medicines containing As in Chinese patent medicine such as As4S4, As2S3, etc. Due to the toxicity of As-containing compounds and its role in inflammation and treatment of cancers such as leukemia, it is necessary to analyze the chemical form of As. A comprehensive investigation of the compound forms of heavy metals rather than the simple total amount of elements will lay the foundation for the scientific and objective evaluation of the safety of heavy metals. This article summarizes the speciation of As in bulk Chinese medicinal materials and Chinese patent medicines in recent years, and reviews the main research methods of As speciation analysis. The separation and detection combined analysis method focuses on the high-performance liquid chromatography-plasma mass spectrometry and high-performance liquid chromatography-hydride generation-atomic fluorescence spectroscopy, etc. Taking the advanced synchrotron radiation source as the research platform, the use of X-ray near edge absorption fine structure spectrum and micro-area X-ray fluorescence analysis as a microscopic analysis technique supports direct analysis of the As speciation in situ. It is the most promising morphological analysis method.

Publisher

Walter de Gruyter GmbH

Subject

Materials Chemistry,General Chemistry

Reference80 articles.

1. Xiao XH, Chen SL, Huang LQ, Xiao PG. Introduction to the research of genuine Chinese medicinal materials in the past 20 years. China J Chin Mater Medica. 2009;34(5):519–23. CNKI:SUN:ZGZY.0.2009-05-004.

2. Yuan Y, Chen TY, Huang LQ, Jin Y, Yang J, Zhao YY. Research strategy and application of control authentic medicinal materials. China J Chin Mater Medica. 2017;42(13):2623–6. 10.19540/j.cnki.cjcmm.20170614.005.

3. Ibrar M, Muhammad N, Shah W. Barkatullah. Evaluation of trace and toxic heavy metals in selected crude drugs used in Khyber Pukhtonkhawa, Pakistan. Pak J Botany. 2013;45(1):141–4.

4. Chan CS, Guo L, Shih MC. Statistic analysis of heavy metal residues in Chinese crude drugs with the international standards of Chinese Medicine–Chinese herbal medicine heavy metal limit. Sci Technol Rev. 2017;35(11):91–98. 10.1023/A:1010602031070.

5. Han XL, Zhang XB, Guo LP, Huang LQ, Li MJ, Liu XH, et al. Statistical analysis of residues of heavy metals in Chinese crude drugs. China J Chin Mater Medica. 2008;33(18):2041–8. 10.3724/SP.J.1011.2008.00534.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3